SEC Company Response from ENvue Medical, Inc. (FEED) (CIK 0001326706) (FEED) — Feb 14, 2019
ENvue Medical, Inc. (FEED) (CIK 0001326706)
Date: Feb. 14, 2019 · CIK: 0001326706 · Accession: 0001615774-19-002445
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229106
Letter
NanoVibronix, Inc.
525 Executive Blvd.
Elmsford, NY 10523
February 14, 2019
By EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention: Eric Atallah
RE: NanoVibronix, Inc.
Registration Statement on Form S-3
Filed December 31, 2018
Request for Acceleration
File No. 333-229106
Ladies and Gentlemen:
Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, NanoVibronix, Inc. (the “Company”) hereby requests acceleration of the effective date of the above-mentioned Registration Statement on Form S-3 (the “Registration Statement”) to 5:00 p.m., Eastern Time on February 15, 2019, or as soon thereafter as practicable.
Should any member of the staff of the U.S. Securities and Exchange Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very truly yours,
NanoVibronix, Inc.
Show Raw Text
CORRESP
1
filename1.htm
NanoVibronix, Inc.
525 Executive Blvd.
Elmsford, NY 10523
February 14, 2019
By EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention: Eric Atallah
RE:
NanoVibronix, Inc.
Registration Statement on Form S-3
Filed December 31, 2018
Request for Acceleration
File No. 333-229106
Ladies and Gentlemen:
Pursuant to Rule 461 of
the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities
Act of 1933, as amended, NanoVibronix, Inc. (the “Company”) hereby requests acceleration of the effective date
of the above-mentioned Registration Statement on Form S-3 (the “Registration Statement”) to 5:00 p.m., Eastern
Time on February 15, 2019, or as soon thereafter as practicable.
Should any member of the
staff of the U.S. Securities and Exchange Commission have any questions or comments with respect to this request, please contact
our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very truly yours,
NanoVibronix, Inc.
By:
/s/ Stephen Brown
Stephen Brown
Chief Financial Officer